AstraZeneca Pharma India Limited has announced the resignations of two key senior management personnel: Mr. Ayush Kumar Agarwal, Business Unit Director – Biopharmaceutical Business Unit, and Ms. Shikha Mirchandani Chatrath, Director – Commercial Excellence, BD and Strategy. Both individuals are leaving to pursue career opportunities outside the organization. Mr. Agarwal’s last day will be June 12, 2026, and Ms. Chatrath’s will be August 3, 2026. The company is actively seeking suitable replacements.
Resignations of Key Executives
AstraZeneca Pharma India Limited has officially announced the departure of two senior management executives. Mr. Ayush Kumar Agarwal, serving as the Business Unit Director for the Biopharmaceutical Business Unit, and Ms. Shikha Mirchandani Chatrath, Director of Commercial Excellence, BD and Strategy, have both decided to resign from their positions. The company confirmed that both executives are leaving to pursue external career opportunities.
Cessation Dates and Transition
Mr. Ayush Kumar Agarwal will conclude his tenure and be relieved of his duties by the close of business hours on June 12, 2026. Following him, Ms. Shikha Mirchandani Chatrath will complete her handover period and depart by the close of business hours on August 3, 2026. The company has stated that it is currently in the process of identifying and appointing suitable replacements for these critical roles to ensure seamless operations and continuity.
Company Acknowledges Contributions
AstraZeneca Pharma India Limited expressed its best wishes to both Mr. Agarwal and Ms. Chatrath for their future endeavors. The company acknowledges their contributions during their time with the organization and wishes them success in their subsequent career paths. The announcement was made on June 1, 2026, with the details of the resignations further elaborated in an attached annexure.
Source: BSE
